Makya AI drug-design collaboration with Iktos

Hengrui announced a strategic collaboration with Iktos, which it describes as a French company that develops artificial-intelligence platforms for new-drug design. The page says Hengrui will use Iktos's AI-based de novo design software Makya to accelerate small-molecule discovery and lead-compound optimization.